Back to top

vaccines: Archive

Shaun Pruitt

Time to Buy Pfizer (PFE) or Metsera (MTSR) Stock?

Making a major move in the obesity drug market, Pfizer (PFE) announced on Monday that it plans to acquire biotechnology firm Metsera (MTSR).

PFENegative Net Change NVONegative Net Change LLYNegative Net Change

Sundeep Ganoria

Will the FDA's Nod for Subcutaneous Keytruda Ease Merck's Headwinds?

FDA clears MRK's Keytruda Qlex, a subcutaneous option that promises faster treatment and new patent protection amid looming headwinds.

MRKNegative Net Change MRNAPositive Net Change SMMTNo Net Change